Factors associated with treatment failure for chemotherapy-induced nausea and vomiting (CINV) among breast cancer patients receiving adjuvant chemotherapy

被引：0
|
作者：
Yeo, Winnie
Ngai, Nicole
Yeo, Horatio
Lai, Dong
Pang, Elizabeth
Kwok, Carol
Lau, Thomas
Mo, Frankie
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO1-11-12
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO1-11-12
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Rolapitant for Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Patients With Breast Cancer
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (08) : 6 - 7
  • [2] PantoCIN: Pantoprazole's effectiveness as prophylaxis against delayed Chemotherapy-Induced Nausea and Vomiting (CINV) in patients receiving adjuvant or neoadjuvant breast cancer chemotherapy
    Wewala, Navin
    Sharples, Katrina
    Kim, Yujin
    Benge, Sarah
    Cartwright, Robert
    Clement, Louise
    Huang, Ying
    Isaacs, Richard
    CANCER RESEARCH, 2023, 83 (05)
  • [3] Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) Associated with Moderately Emetogenic (MEC) Chemotherapy in Patients with Breast Cancer
    Webb, T.
    Hardwick, J.
    Carides, A. D.
    Street, J. C.
    CANCER RESEARCH, 2009, 69 (24) : 575S - 576S
  • [4] Rolapitant for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients with breast cancer.
    Schwartzberg, Lee Steven
    Nayari, Rudolph M.
    Arora, Sujata
    Powers, Daniel
    Jordan, Karin
    Rapoport, Bernardo Leon
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [5] CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) - INCIDENCE BY AGE AND SEX AMONG PATIENTS RECEIVING OXALIPLATIN
    Binder, G.
    Saunders, W. B.
    VALUE IN HEALTH, 2018, 21 : S14 - S14
  • [6] Clonazepam for chemotherapy-induced nausea and vomiting (CINV)
    Koga, Minako
    Nakadozono, Momoe
    Nukariya, Kazutaka
    Nogi, Hiroko
    Kobayashi, Tadashi
    Nakayama, Kazuhiko
    ANTICANCER RESEARCH, 2008, 28 (4C) : 2433 - 2436
  • [7] Analysis of pharmacogenomic factors for chemotherapy-induced nausea and vomiting in patients with breast cancer receiving doxorubicin and cyclophosphamide chemotherapy
    Daiki Tsuji
    Megumi Matsumoto
    Yohei Kawasaki
    Yong-I. L. Kim
    Keisuke Yamamoto
    Hidenori Nakamichi
    Yuri Sahara
    Ryo Makuta
    Mari Yokoi
    Takehiro Miyagi
    Kunihiko Itoh
    Cancer Chemotherapy and Pharmacology, 2021, 87 : 73 - 83
  • [8] Analysis of pharmacogenomic factors for chemotherapy-induced nausea and vomiting in patients with breast cancer receiving doxorubicin and cyclophosphamide chemotherapy
    Tsuji, Daiki
    Matsumoto, Megumi
    Kawasaki, Yohei
    Kim, Yong-I. L.
    Yamamoto, Keisuke
    Nakamichi, Hidenori
    Sahara, Yuri
    Makuta, Ryo
    Yokoi, Mari
    Miyagi, Takehiro
    Itoh, Kunihiko
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2021, 87 (01) : 73 - 83
  • [9] Dronabinol treatment of delayed chemotherapy-induced nausea and vomiting (CINV).
    Meiri, E
    Jhangiani, H
    Vredenburgh, J
    Barbato, L
    Yang, H
    Li, D
    Baranowski, V
    Tse, N
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 733S - 733S
  • [10] Clinical Predictors of Chemotherapy-induced Nausea and Vomiting in Breast Cancer Patients Receiving Adjuvant Doxorubicin and Cyclophosphamide
    Shih, Vivianne
    Wan, Hee Siew
    Chan, Alexandre
    ANNALS OF PHARMACOTHERAPY, 2009, 43 (03) : 444 - 452
12345